Netherlands: Medicaments Containing Insulin Market 2023

Medicaments Containing Insulin Market Size in the Netherlands

The Dutch medicaments containing insulin market surged to $X in 2022, picking up by X% against the previous year. In general, consumption, however, enjoyed significant growth. Medicaments containing insulin consumption peaked at $X in 2019; however, from 2020 to 2022, consumption stood at a somewhat lower figure.

Medicaments Containing Insulin Production in the Netherlands

In value terms, medicaments containing insulin production reduced remarkably to $X in 2022 estimated in export price. In general, production, however, showed a sharp shrinkage. The growth pace was the most rapid in 2019 with a decrease of X% against the previous year. Over the period under review, production hit record highs at $X in 2017; however, from 2018 to 2022, production remained at a lower figure.

Medicaments Containing Insulin Exports

Exports from the Netherlands

In 2022, shipments abroad of medicaments containing insulin but not antibiotics increased by X% to X tons for the first time since 2017, thus ending a four-year declining trend. In general, exports, however, faced a sharp decrease. The exports peaked at X tons in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

In value terms, medicaments containing insulin exports surged to $X in 2022. Overall, exports, however, saw a sharp decline. The most prominent rate of growth was recorded in 2021 when exports increased by X% against the previous year. Over the period under review, the exports attained the maximum at $X in 2017; however, from 2018 to 2022, the exports failed to regain momentum.

Exports by Country

The UK (X tons) was the main destination for medicaments containing insulin exports from the Netherlands, with a X% share of total exports. It was followed by India (X kg), with a X% share of total exports.

From 2017 to 2022, the average annual rate of growth in terms of volume to the UK amounted to X%.

In value terms, the UK ($X) remains the key foreign market for medicaments containing insulin but not antibiotics exports from the Netherlands, comprising X% of total exports. The second position in the ranking was taken by India ($X), with a X% share of total exports.

From 2017 to 2022, the average annual growth rate of value to the UK stood at X.5%.

Export Prices by Country

The average medicaments containing insulin export price stood at $X per ton in 2022, falling by X% against the previous year. In general, the export price, however, enjoyed a significant expansion. The pace of growth appeared the most rapid in 2021 when the average export price increased by X% against the previous year. As a result, the export price reached the peak level of $X per ton, and then contracted notably in the following year.

Average prices varied noticeably for the major foreign markets. In 2022, amid the top suppliers, the country with the highest price was India ($X per ton), while the average price for exports to the UK amounted to $X per ton.

From 2017 to 2022, the most notable rate of growth in terms of prices was recorded for supplies to the UK (X%).

Medicaments Containing Insulin Imports

Imports into the Netherlands

In 2022, the amount of medicaments containing insulin but not antibiotics imported into the Netherlands reduced sharply to X kg, waning by X% against the year before. In general, imports recorded a abrupt descent. The growth pace was the most rapid in 2019 with an increase of X%. As a result, imports reached the peak of X tons. From 2020 to 2022, the growth of imports remained at a lower figure.

In value terms, medicaments containing insulin imports skyrocketed to $X in 2022. Over the period under review, imports, however, showed a strong expansion. The pace of growth appeared the most rapid in 2019 when imports increased by X%. As a result, imports attained the peak of $X. From 2020 to 2022, the growth of imports remained at a somewhat lower figure.

Imports by Country

In 2022, Belgium (X kg) constituted the largest medicaments containing insulin supplier to the Netherlands, accounting for a X% share of total imports. Moreover, medicaments containing insulin imports from Belgium exceeded the figures recorded by the second-largest supplier, the UK (X kg), fivefold. Poland (X kg) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of volume from Belgium stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (X% per year) and Poland (X% per year).

In value terms, Belgium ($X) constituted the largest supplier of medicaments containing insulin but not antibiotics to the Netherlands, comprising X% of total imports. The second position in the ranking was taken by the UK ($X), with an X% share of total imports. It was followed by Poland, with a X% share.

From 2012 to 2022, the average annual rate of growth in terms of value from Belgium amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: the UK (X% per year) and Poland (X% per year).

Import Prices by Country

The average medicaments containing insulin import price stood at $X per ton in 2022, picking up by X% against the previous year. Over the period under review, the import price showed a significant expansion. As a result, import price attained the peak level and is likely to continue growth in the immediate term.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was Belgium ($X per ton), while the price for Hungary ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by Belgium (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :